Incremental Value of NT‐proBNP Over HCM‐AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy

Documenti analoghi

• Obesity Paradox and the Effect of NT‐proBNP on All‐Cause and Cause‐Specific Mortality
  di: Rupinder Kaur Bahniwal, et al.
  Pubblicazione: (2024)
• Incidence Rate and Predictors of Intracranial Hemorrhage in Patients With Atrial Fibrillation: A Report From the Nationwide COOL‐AF Registry
  di: Rungroj Krittayaphong, et al.
  Pubblicazione: (2024)
• Application Value and Safety Analysis of Warfarin, Rivaroxaban, and Dabigatran Ester in Elderly Patients With Atrial Fibrillation
  di: Cheng Chen, et al.
  Pubblicazione: (2024)
• A Novel Clinical Score Integrating Low‐Voltage Zones and Biomarkers Predicts Atrial Fibrillation Recurrence Post‐Ablation
  di: Ying Han, et al.
  Pubblicazione: (2025)
• Generalizability of Low‐Voltage Zone‐Based Risk Scores After Atrial Fibrillation Ablation
  di: Laiba Anwar, et al.
  Pubblicazione: (2026)